Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001860742-26-000050
Filing Date
2026-03-03
Accepted
2026-03-03 16:24:35
Documents
1
Period of Report
2026-02-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4819
  Complete submission text file 0001860742-26-000050.txt   6221
Mailing Address C/O BLCO 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807
Business Address
VON ESCHENBACH ANDREW C. (Reporting) CIK: 0001536529 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41380 | Film No.: 26714710

Mailing Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4
Business Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 908-541-5456
Bausch & Lomb Corp (Issuer) CIK: 0001860742 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)